ArabFinance: Alexandria Pharmaceuticals (AXPH) announced in a statement sent to EGX, the Board of Directors (BoD) was held on Dec. 07.
The company's BoD approved financial results for the fiscal period starting July 01, 2019 and ending October 30, 2019, which revealed posting after-tax profits of EGP 52,773,320, compared to net profits of EGP 41,189,869 a year earlier, with a 28% profit increase.
Copyright © 2019 Arab Finance Brokerage Company All rights reserved. Provided by SyndiGate Media Inc. (Syndigate.info).
Disclaimer: The content of this article is syndicated or provided to this website from an external third party provider. We are not responsible for, and do not control, such external websites, entities, applications or media publishers. The body of the text is provided on an “as is” and “as available” basis and has not been edited in any way. Neither we nor our affiliates guarantee the accuracy of or endorse the views or opinions expressed in this article. Read our full disclaimer policy here.
